RM 84.00


Glucosamine sulfate.

Each sachet contains crystalline glucosamine sulfate 1884 mg (eq. to Glucosamine sulfate 1500 mg).

Adjuvant therapy for osteoarthritis.

Dosage/Direction for Use
The content of one sachet (dissolved in a glass of water) should be taken orally once daily, preferably at meals.
Duration of treatment: 6 to 8 weeks

Symptoms and Treatment of Overdose: No cases of accidental or intentional overdose are known. The animal acute and chronic toxicological studies indicate that toxic effects and symptoms of toxicity are not likely to occur, even after high overdoses.

Hypersensitivity to glucosamine.
The powder for oral solution contains aspartame and is therefore contraindicated in patients with phenylketonuria.

Special Precautions
The administration of Gluco-S1500 in patients with severe hepatic or renal insufficiency, patients with diabetes and people who are allergic to shellfish should be made under medical supervision.
No effect on the ability to drive or to operate machinery is expected.

Use In Pregnancy & Lactation
The animal studies did not evidence any unfavourable effects on the reproductive functions or on lactation. In the absence of such studies in humans, the product during pregnancy and lactation should not be taken unless advised by the doctor. Administration during the first three months of pregnancy must be avoided.

Adverse Reactions
The clinical trials have shown good tolerability of the product. Undesirable effects have been observed in a low proportion of patients. They were transient and of minor entity, and included gastric discomfort and pain, meteorism, constipation or diarrhoea.
Cardiovascular: Peripheral oedema, tachycardia were reported in a few patients following larger clinical trials investigating oral administration in osteoarthritis. Causal relationship has not been established.
Central nervous system: Drowsiness, headache, insomnia have been observed rarely during therapy (less than 1%).
Gastrointestinal: Nausea, vomiting, diarrhoea, dyspepsia or epigastric pain, constipation, heartburn and anorexia have been described rarely during oral therapy with glucosamine.
Skin: Skin reactions such as erythema and prurltus have been reported with therapeutic administration of glucosamine.
The patient should inform his doctor of any undesirable effect during treatment.

Drug Interactions
The use of Glucosamine with oral hypoglycaemic agent may reduce the oral hypoglycaemic agent effectiveness.

Store at a place under 30°C.
Shelf-Life: 3 years.


Product Review

Back to List